Assessment of the impact of a personalised nutrition intervention in impaired glucose regulation over 26 weeks: a randomised controlled trial

Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports Jg. 14; H. 1; S. 5428 - 13
Hauptverfasser: Karvela, Maria, Golden, Caroline T., Bell, Nikeysha, Martin-Li, Stephanie, Bedzo-Nutakor, Judith, Bosnic, Natalie, DeBeaudrap, Pierre, de Mateo-Lopez, Sara, Alajrami, Ahmed, Qin, Yun, Eze, Maria, Hon, Tsz-Kin, Simón-Sánchez, Javier, Sahoo, Rashmita, Pearson-Stuttard, Jonathan, Soon-Shiong, Patrick, Toumazou, Christofer, Oliver, Nick
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 05.03.2024
Nature Publishing Group
Nature Portfolio
Schlagworte:
ISSN:2045-2322, 2045-2322
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (− 0.13 mmol/L (95% CI [− 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (− 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (− 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (− 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent. Trial Registration: www.clinicaltrials.gov.uk Ref: NCT03702465.
AbstractList Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (- 0.13 mmol/L (95% CI [- 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (- 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (- 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (- 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent.Trial Registration: www.clinicaltrials.gov.uk Ref: NCT03702465.Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (- 0.13 mmol/L (95% CI [- 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (- 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (- 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (- 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent.Trial Registration: www.clinicaltrials.gov.uk Ref: NCT03702465.
Abstract Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (− 0.13 mmol/L (95% CI [− 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (− 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (− 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (− 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent. Trial Registration: www.clinicaltrials.gov.uk Ref: NCT03702465.
Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (− 0.13 mmol/L (95% CI [− 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (− 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (− 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (− 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent. Trial Registration: www.clinicaltrials.gov.uk Ref: NCT03702465.
Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (− 0.13 mmol/L (95% CI [− 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (− 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (− 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (− 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent. Trial Registration: www.clinicaltrials.gov.uk Ref: NCT03702465.
Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (- 0.13 mmol/L (95% CI [- 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (- 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (- 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (- 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent.Trial Registration: www.clinicaltrials.gov.uk Ref: NCT03702465.
Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46). The primary outcome was the difference in fasting plasma glucose (FPG) between the Control and Intervention arms after 6 weeks. 180 people were recruited, of whom 148 people were randomised, mean age of 59 years (SD = 11), 69% of whom were female. There was no significant difference in the FPG change between the Control and Intervention arms at 6 weeks (− 0.13 mmol/L (95% CI [− 0.37, 0.11]), p = 0.29), however, we found that a DNA-personalised dietary intervention led to a significant reduction of FPG at 26 weeks in the Intervention arm when compared to standard care (− 0.019 (SD = 0.008), p = 0.01), as did the Exploratory arm (− 0.021 (SD = 0.008), p = 0.006). HbA1c at 26 weeks was significantly reduced in the Intervention arm when compared to standard care (− 0.038 (SD = 0.018), p = 0.04). There was some evidence suggesting prevention of progression to T2DM across the groups that received a DNA-based intervention (p = 0.06). Personalisation of dietary advice based on DNA did not result in glucose changes within the first 6 weeks but was associated with significant reduction of FPG and HbA1c at 26 weeks when compared to standard care. The DNA-based diet was effective regardless of intervention type, though results should be interpreted with caution due to the low sample size. These findings suggest that DNA-based dietary guidance is an effective intervention compared to standard care, but there is still a minimum timeframe of adherence to the intervention before changes in clinical outcomes become apparent.Trial Registration:www.clinicaltrials.gov.uk Ref: NCT03702465.
ArticleNumber 5428
Author Alajrami, Ahmed
Eze, Maria
Karvela, Maria
de Mateo-Lopez, Sara
Bedzo-Nutakor, Judith
Toumazou, Christofer
Hon, Tsz-Kin
Soon-Shiong, Patrick
DeBeaudrap, Pierre
Sahoo, Rashmita
Bosnic, Natalie
Martin-Li, Stephanie
Simón-Sánchez, Javier
Qin, Yun
Pearson-Stuttard, Jonathan
Golden, Caroline T.
Oliver, Nick
Bell, Nikeysha
Author_xml – sequence: 1
  givenname: Maria
  orcidid: 0000-0001-6369-2786
  surname: Karvela
  fullname: Karvela, Maria
  organization: Department of Electrical and Electronic Engineering, Imperial College London, DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 2
  givenname: Caroline T.
  orcidid: 0000-0003-2530-3975
  surname: Golden
  fullname: Golden, Caroline T.
  organization: Department of Electrical and Electronic Engineering, Imperial College London, DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 3
  givenname: Nikeysha
  orcidid: 0000-0002-6504-6443
  surname: Bell
  fullname: Bell, Nikeysha
  organization: DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 4
  givenname: Stephanie
  surname: Martin-Li
  fullname: Martin-Li, Stephanie
  organization: Department of Electrical and Electronic Engineering, Imperial College London, DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 5
  givenname: Judith
  surname: Bedzo-Nutakor
  fullname: Bedzo-Nutakor, Judith
  organization: Department of Electrical and Electronic Engineering, Imperial College London, DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 6
  givenname: Natalie
  surname: Bosnic
  fullname: Bosnic, Natalie
  organization: Department of Electrical and Electronic Engineering, Imperial College London, DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 7
  givenname: Pierre
  orcidid: 0000-0002-9037-6057
  surname: DeBeaudrap
  fullname: DeBeaudrap, Pierre
  organization: Centre for Population and Development (Ceped), French National Institute for Sustainable Development (IRD), and Paris University, Inserm ERL
– sequence: 8
  givenname: Sara
  orcidid: 0000-0003-4754-6599
  surname: de Mateo-Lopez
  fullname: de Mateo-Lopez, Sara
  organization: Department of Electrical and Electronic Engineering, Imperial College London, DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 9
  givenname: Ahmed
  surname: Alajrami
  fullname: Alajrami, Ahmed
  organization: DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 10
  givenname: Yun
  surname: Qin
  fullname: Qin, Yun
  organization: DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 11
  givenname: Maria
  surname: Eze
  fullname: Eze, Maria
  organization: DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 12
  givenname: Tsz-Kin
  surname: Hon
  fullname: Hon, Tsz-Kin
  organization: DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 13
  givenname: Javier
  surname: Simón-Sánchez
  fullname: Simón-Sánchez, Javier
  organization: DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 14
  givenname: Rashmita
  surname: Sahoo
  fullname: Sahoo, Rashmita
  organization: DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 15
  givenname: Jonathan
  orcidid: 0000-0003-2175-9975
  surname: Pearson-Stuttard
  fullname: Pearson-Stuttard, Jonathan
  organization: School of Public Health, Imperial College London
– sequence: 16
  givenname: Patrick
  surname: Soon-Shiong
  fullname: Soon-Shiong, Patrick
  organization: Department of Electrical and Electronic Engineering, Imperial College London
– sequence: 17
  givenname: Christofer
  orcidid: 0000-0001-8773-7360
  surname: Toumazou
  fullname: Toumazou, Christofer
  email: c.toumazou@imperial.ac.uk
  organization: Department of Electrical and Electronic Engineering, Imperial College London, DnaNudge Ltd, Scale Space, Imperial College London
– sequence: 18
  givenname: Nick
  orcidid: 0000-0003-3525-3633
  surname: Oliver
  fullname: Oliver, Nick
  organization: Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38443427$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04553988$$DView record in HAL
BookMark eNp9ks1u1DAUhSNUREvpC7BAkdjAIuDfxGaDRhXQSiOxgbXl2DczHjzxYCeDeAmegWfhyfAkLbSzaDbxzzmf7XvP0-KkDz0UxXOM3mBExdvEMJeiQoRVnGPEq_pRcUYQ4xWhhJzcGZ8WFyltUP44kQzLJ8UpFYxRRpqz4tciJUhpC_1Qhq4c1lC67U6baabLHcQUeu1dAlv24xDd4EJfun6AuM-eeTJZXMySlR9NSFBGWI1eT9thD7Ek9Z_fPwC-pXcZGnVvw3ZCmtAPMXifh5mt_bPicad9goub_3nx9eOHL5dX1fLzp-vLxbIyvOFDRXDXScFFR3XdiBazBkBaYiVrDIOWdLLlTGPaAaZ1x5Ew3FIwppbEINtqel5cz1wb9Ebtotvq-FMF7dS0EOJK6Tg440EB4rZD1nYAnGWebGvBuEYSSYyMtZn1fmbtxnYL1uSyRO3vQe_v9G6tVmGvcCawhjeZ8HomrI98V4ulOqzlVnIqhdjjrH11c1oM30dIg8qVNOC97iGMSRFJBcmlESJLXx5JN2GMuZuTqmGybsgB-OLu9f-df5uRLBCzwMSQUoROGTdMvc2vcT4_Qx0SqeZEqpxINSVS1dlKjqy39AdNdDalLO5XEP9f-wHXX79-9jE
CitedBy_id crossref_primary_10_1080_10408398_2025_2461237
crossref_primary_10_3390_nu17071260
crossref_primary_10_2147_DMSO_S528619
crossref_primary_10_1016_j_obmed_2025_100622
crossref_primary_10_3390_genes16050578
crossref_primary_10_1016_j_advnut_2025_100382
crossref_primary_10_2196_67507
Cites_doi 10.1056/NEJMoa2116747
10.1186/s40795-020-00370-7
10.1038/s41591-020-0934-0
10.1016/j.cell.2015.11.001
10.1177/1559827615619159
10.7326/0003-4819-159-8-201310150-00007
10.2337/dc12-0544
10.1016/j.eclinm.2021.100960
10.1093/hmg/ddv186
10.1016/j.cmpb.2021.106370
10.1186/s40842-019-0080-0
10.1093/ajcn/83.2.443S
10.1016/j.jand.2014.03.014
10.3945/ajcn.116.145680
10.3390/nu12123768
10.1016/j.athplu.2023.09.002
10.1016/j.amepre.2015.01.003
10.1038/s41588-022-01058-3
10.3945/ajcn.117.156281
10.1016/j.jfutfo.2022.06.001
10.1016/j.diabet.2018.08.012
10.1198/000313001753272466
10.1111/j.1462-8902.2004.00315.x
10.1111/dme.13895
10.3390/ijms20122983
10.1037/0033-2909.102.1.159
10.1007/s00125-022-05721-6
10.1186/s12966-021-01136-5
10.1186/s12916-022-02254-y
10.1900/RDS.2012.9.6
10.1136/bmj.g1610
10.2174/157339910793499092
10.1007/s12263-013-0352-8
10.1136/bmj.c332
10.1038/s42255-021-00383-x
10.1056/NEJMoa1605086
10.1001/jamacardio.2018.1717
10.1038/s41574-020-0381-5
10.1212/WNL.0000000000008932
10.1007/s12263-014-0445-z
10.1017/S0007114508020369
10.1136/bmjnph-2020-000073
10.1186/1475-2891-6-29
10.2337/dc11-0442
10.3945/ajcn.2009.28379
10.2337/db11-1799
10.3390/nu13124283
10.1080/14737159.2017.1311208
10.1007/s11883-023-01148-5
10.1186/1475-2840-11-137
10.1097/00001648-200005000-00007
10.1186/s12986-016-0092-z
10.3390/nu9080913
10.1016/j.pcd.2018.07.003
10.1093/ajcn/86.3.752
10.1056/NEJMoa1203039
10.1093/ije/dyaa135
10.1159/000505662
10.1007/s00125-019-4864-7
10.1056/NEJMoa012512
10.1007/978-3-642-11760-2_2
10.1161/CIRCGENETICS.109.891366
10.2337/dc21-1051
10.3945/ajcn.115.122820
10.1002/oby.20958
10.1210/en.2018-00591
10.2337/dc10-0666
10.3945/ajcn.115.121186
10.2337/dc06-0560
10.1016/S2213-8587(18)30037-8
10.1177/1932296817713506
10.1111/ijcp.12384
10.1111/j.2517-6161.1964.tb00553.x
10.2337/cd20-pe04
10.1172/jci.insight.122011
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
1XC
VOOES
5PM
DOA
DOI 10.1038/s41598-024-55105-6
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


CrossRef
MEDLINE
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 13
ExternalDocumentID oai_doaj_org_article_e05df0ddfee54e139b6845a090910cdd
PMC10914757
oai:HAL:hal-04553988v1
38443427
10_1038_s41598_024_55105_6
Genre Randomized Controlled Trial
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
AFPKN
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
Q9U
7X8
PUEGO
1XC
VOOES
5PM
ID FETCH-LOGICAL-c575t-21ff9858f3a678b147ee9d2d947c4eb2f9b54a13fe136f508c5d3ecc692c0dba3
IEDL.DBID DOA
ISICitedReferencesCount 9
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001180457200034&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2045-2322
IngestDate Tue Oct 14 19:08:25 EDT 2025
Tue Nov 04 02:05:48 EST 2025
Tue Oct 14 20:43:47 EDT 2025
Thu Oct 02 11:36:38 EDT 2025
Tue Oct 07 07:47:18 EDT 2025
Mon Jul 21 06:05:20 EDT 2025
Sat Nov 29 01:58:06 EST 2025
Tue Nov 18 21:08:20 EST 2025
Fri Feb 21 02:39:40 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2024. The Author(s).
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c575t-21ff9858f3a678b147ee9d2d947c4eb2f9b54a13fe136f508c5d3ecc692c0dba3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0002-6504-6443
0000-0002-9037-6057
0000-0003-4754-6599
0000-0001-8773-7360
0000-0003-2530-3975
0000-0003-2175-9975
0000-0001-6369-2786
0000-0003-3525-3633
OpenAccessLink https://doaj.org/article/e05df0ddfee54e139b6845a090910cdd
PMID 38443427
PQID 2937496721
PQPubID 2041939
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_e05df0ddfee54e139b6845a090910cdd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10914757
hal_primary_oai_HAL_hal_04553988v1
proquest_miscellaneous_2938285888
proquest_journals_2937496721
pubmed_primary_38443427
crossref_citationtrail_10_1038_s41598_024_55105_6
crossref_primary_10_1038_s41598_024_55105_6
springer_journals_10_1038_s41598_024_55105_6
PublicationCentury 2000
PublicationDate 2024-03-05
PublicationDateYYYYMMDD 2024-03-05
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-03-05
  day: 05
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Holzapfel, Dawczynski, Henze, Simon (CR68) 2021; 68
de Toro-Martín (CR37) 2018; 3
Goni (CR51) 2017; 106
Tan, Mitra (CR36) 2020; 13
Merino (CR72) 2022; 65
Neil Thomas (CR13) 2010; 6
Galaviz, Narayan, Lobelo, Weber (CR3) 2018; 12
CR79
Wilding (CR63) 2014; 68
Moore (CR64) 2000; 11
Pollard, Richardson (CR57) 1987; 102
Box, Cox (CR59) 1964; 26
Goni, Cuervo, Milagro, Martínez (CR24) 2015; 10
Shan, Sarkar, Martin (CR73) 2019; 62
Hostalek (CR12) 2019; 5
Tillin (CR77) 2013; 36
Magkos, Hjorth, Astrup (CR61) 2020; 16
Celis-Morales (CR49) 2017; 105
Wyatt, Berry, Finlayson, O’Driscoll, Hadjigeorgiou, Drew (CR45) 2021; 3
Bo (CR4) 2009; 90
Fukuoka, Gay, Joiner, Vittinghoff (CR55) 2015; 49
Hamman (CR62) 2006; 29
Nkhoma (CR74) 2021; 210
Mahajan (CR52) 2022; 54
Nagar, Nápoles, Jordan, Mariño-Ramírez (CR78) 2021; 37
Livingstone, Abbott, Ward, Bowe (CR10) 2021; 13
Kiani (CR47) 2022; 63
Fagherazzi, Ravaud (CR76) 2019; 45
Giovannucci (CR54) 2010; 33
Ordovas (CR21) 2006; 83
Hong (CR22) 2023; 25
Vranceanu (CR35) 2020; 6
Goff (CR80) 2019; 36
Zhang (CR32) 2012; 61
Sumamo Schellenberg, Dryden, Vandermeer, Ha, Korownyk (CR14) 2013; 159
Glechner (CR15) 2018; 12
(CR67) 2002; 346
Sablerolles (CR9) 2022; 386
Nettleton (CR6) 2015; 24
Faith, Kral (CR8) 2006
Olsen (CR26) 2016; 104
Qi (CR29) 2014; 348
Pogran (CR46) 2023; 54
Abdullah Said, Verweij, Van Der Harst (CR2) 2018; 3
Cornelis, El-Sohemy, Campos (CR20) 2007; 86
Berry (CR44) 2020; 26
Horne, Gilliland, O’Connor, Seabrook, Madill (CR30) 2020; 3
Schulz, Altman, Moher (CR60) 2010; 340
de Toro-Martín, Arsenault, Després, Vohl (CR17) 2017; 9
Koochakpoor (CR48) 2016; 13
Ortega-Azorín (CR42) 2012; 11
Zeevi (CR16) 2015; 163
Zhuang (CR40) 2021; 44
Parrillo (CR53) 2019; 20
Aucott (CR65) 2004; 6
Jones (CR66) 2020; 49
Greenwood, Gee, Fatkin, Peeples (CR75) 2017; 11
Chen, Chen (CR69) 2022; 2
Hu (CR5) 2011; 34
Yang, Tsiatis (CR56) 2001; 55
Casas-Agustench (CR28) 2014; 114
Verbeke, Molenberghs, Rizopoulos, van Montfort, Oud, Satorra (CR58) 2010
Huang (CR39) 2016; 104
Meisel, Beeken, Van Jaarsveld, Wardle (CR34) 2015; 23
Ramos-Lopez (CR70) 2017; 10
Khera (CR11) 2016; 375
Heianza, Qi (CR7) 2019; 160
Horne, Gilliland, Vohl, Madill (CR31) 2020; 12
Corella, Coltell, Mattingley, Sorlí, Ordovas (CR18) 2017; 17
Qin (CR23) 2020; 94
Livingstone (CR50) 2021; 18
Rukh (CR25) 2013; 8
Qi (CR27) 2012; 367
Rein (CR43) 2022; 20
Wang, Hu (CR71) 2018; 6
Arkadianos (CR38) 2007; 6
Corella, Ordovas (CR19) 2009; 2
Fisher (CR41) 2009; 101
Arkadianos (CR33) 2007; 6
Murea, Ma, Freedman (CR1) 2012; 9
C Ortega-Azorín (55105_CR42) 2012; 11
S Jones (55105_CR66) 2020; 49
D Zeevi (55105_CR16) 2015; 163
MS Faith (55105_CR8) 2006
E Sumamo Schellenberg (55105_CR14) 2013; 159
T Huang (55105_CR39) 2016; 104
RSG Sablerolles (55105_CR9) 2022; 386
BV Hong (55105_CR22) 2023; 25
C Holzapfel (55105_CR68) 2021; 68
JR Horne (55105_CR31) 2020; 12
NJ Olsen (55105_CR26) 2016; 104
P Pollard (55105_CR57) 1987; 102
L Parrillo (55105_CR53) 2019; 20
Diabetes Prevention Program Research Group (55105_CR67) 2002; 346
LM Goff (55105_CR80) 2019; 36
J de Toro-Martín (55105_CR37) 2018; 3
Y Heianza (55105_CR7) 2019; 160
AV Khera (55105_CR11) 2016; 375
RF Hamman (55105_CR62) 2006; 29
P Wyatt (55105_CR45) 2021; 3
SD Nagar (55105_CR78) 2021; 37
L Aucott (55105_CR65) 2004; 6
J de Toro-Martín (55105_CR17) 2017; 9
PY Tan (55105_CR36) 2020; 13
J Horne (55105_CR30) 2020; 3
KM Livingstone (55105_CR50) 2021; 18
E Giovannucci (55105_CR54) 2010; 33
LL Moore (55105_CR64) 2000; 11
I Arkadianos (55105_CR33) 2007; 6
55105_CR79
J Merino (55105_CR72) 2022; 65
I Arkadianos (55105_CR38) 2007; 6
G Koochakpoor (55105_CR48) 2016; 13
M Rein (55105_CR43) 2022; 20
F Magkos (55105_CR61) 2020; 16
P Casas-Agustench (55105_CR28) 2014; 114
A Mahajan (55105_CR52) 2022; 54
E Pogran (55105_CR46) 2023; 54
C Celis-Morales (55105_CR49) 2017; 105
X Zhang (55105_CR32) 2012; 61
P Zhuang (55105_CR40) 2021; 44
G Fagherazzi (55105_CR76) 2019; 45
O Ramos-Lopez (55105_CR70) 2017; 10
G Neil Thomas (55105_CR13) 2010; 6
S Bo (55105_CR4) 2009; 90
MC Cornelis (55105_CR20) 2007; 86
SE Berry (55105_CR44) 2020; 26
GEP Box (55105_CR59) 1964; 26
L Goni (55105_CR24) 2015; 10
Q Qi (55105_CR29) 2014; 348
T Tillin (55105_CR77) 2013; 36
M Abdullah Said (55105_CR2) 2018; 3
FB Hu (55105_CR5) 2011; 34
L Goni (55105_CR51) 2017; 106
KI Galaviz (55105_CR3) 2018; 12
JM Ordovas (55105_CR21) 2006; 83
JPH Wilding (55105_CR63) 2014; 68
D Corella (55105_CR18) 2017; 17
G Verbeke (55105_CR58) 2010
R Shan (55105_CR73) 2019; 62
DD Wang (55105_CR71) 2018; 6
JA Nettleton (55105_CR6) 2015; 24
DE Nkhoma (55105_CR74) 2021; 210
Y Fukuoka (55105_CR55) 2015; 49
M Vranceanu (55105_CR35) 2020; 6
E Fisher (55105_CR41) 2009; 101
U Hostalek (55105_CR12) 2019; 5
D Corella (55105_CR19) 2009; 2
KM Livingstone (55105_CR10) 2021; 13
G Rukh (55105_CR25) 2013; 8
A Glechner (55105_CR15) 2018; 12
KF Schulz (55105_CR60) 2010; 340
Q Qi (55105_CR27) 2012; 367
DA Greenwood (55105_CR75) 2017; 11
AK Kiani (55105_CR47) 2022; 63
L Yang (55105_CR56) 2001; 55
M Murea (55105_CR1) 2012; 9
SF Meisel (55105_CR34) 2015; 23
R Chen (55105_CR69) 2022; 2
X Qin (55105_CR23) 2020; 94
References_xml – volume: 386
  start-page: 951
  year: 2022
  end-page: 963
  ident: CR9
  article-title: Immunogenicity and reactogenicity of vaccine boosters after Ad26.COV2.S priming
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2116747
– volume: 6
  start-page: 7
  year: 2020
  ident: CR35
  article-title: A comparison of a ketogenic diet with a LowGI/nutrigenetic diet over 6 months for weight loss and 18-month follow-up
  publication-title: BMC Nutr.
  doi: 10.1186/s40795-020-00370-7
– volume: 26
  start-page: 964
  year: 2020
  end-page: 973
  ident: CR44
  article-title: Human postprandial responses to food and potential for precision nutrition
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0934-0
– volume: 163
  start-page: 1079
  year: 2015
  end-page: 1094
  ident: CR16
  article-title: Personalized nutrition by prediction of glycemic responses
  publication-title: Cell
  doi: 10.1016/j.cell.2015.11.001
– volume: 12
  start-page: 4
  year: 2018
  ident: CR3
  article-title: Lifestyle and the prevention of type 2 diabetes: A status report
  publication-title: Am. J. Lifestyle Med.
  doi: 10.1177/1559827615619159
– volume: 159
  start-page: 543
  year: 2013
  end-page: 551
  ident: CR14
  article-title: Lifestyle interventions for patients with and at risk for type 2 diabetes: A systematic review and meta-analysis
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-159-8-201310150-00007
– volume: 36
  start-page: 383
  year: 2013
  end-page: 393
  ident: CR77
  article-title: Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: The Southall and Brent REVISITED (SABRE) cohort
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0544
– year: 2006
  ident: CR8
  publication-title: Social Environmental and Genetic Influences on Obesity and Obesity-Promoting Behaviors: Fostering Research Integration
– volume: 37
  start-page: 100960
  year: 2021
  ident: CR78
  article-title: Socioeconomic deprivation and genetic ancestry interact to modify type 2 diabetes ethnic disparities in the United Kingdom
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2021.100960
– volume: 24
  start-page: 4728
  year: 2015
  end-page: 4738
  ident: CR6
  article-title: Gene × dietary pattern interactions in obesity: Analysis of up to 68,317 adults of European ancestry
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddv186
– volume: 210
  start-page: 106370
  year: 2021
  ident: CR74
  article-title: Digital interventions self-management education for type 1 and 2 diabetes: A systematic review and meta-analysis
  publication-title: Comput. Methods Progr. Biomed.
  doi: 10.1016/j.cmpb.2021.106370
– volume: 5
  start-page: 1
  year: 2019
  ident: CR12
  article-title: Global epidemiology of prediabetes—Present and future perspectives
  publication-title: Clin. Diabetes Endocrinol.
  doi: 10.1186/s40842-019-0080-0
– volume: 83
  start-page: 443S
  year: 2006
  end-page: 446S
  ident: CR21
  article-title: Genetic interactions with diet influence the risk of cardiovascular disease
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/83.2.443S
– volume: 114
  start-page: 1954
  year: 2014
  end-page: 1966
  ident: CR28
  article-title: Saturated fat intake modulates the association between an obesity genetic risk score and body mass index in two US populations
  publication-title: J. Acad. Nutr. Diet
  doi: 10.1016/j.jand.2014.03.014
– volume: 105
  start-page: 1204
  year: 2017
  end-page: 1213
  ident: CR49
  article-title: Can genetic-based advice help you lose weight? Findings from the Food4Me European randomized controlled trial
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.116.145680
– volume: 12
  start-page: 3768
  year: 2020
  ident: CR31
  article-title: Exploring attitudes, subjective norms and perceived behavioural control in a genetic-based and a population-based weight management intervention: A one-year randomized controlled trial
  publication-title: Nutrients
  doi: 10.3390/nu12123768
– volume: 54
  start-page: 14
  year: 2023
  end-page: 21
  ident: CR46
  article-title: The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome
  publication-title: Atheroscler. Plus
  doi: 10.1016/j.athplu.2023.09.002
– volume: 49
  start-page: 223
  year: 2015
  end-page: 237
  ident: CR55
  article-title: A novel diabetes prevention intervention using a mobile app: A randomized controlled trial with overweight adults at risk
  publication-title: Am. J. Prev. Med.
  doi: 10.1016/j.amepre.2015.01.003
– volume: 54
  start-page: 560
  year: 2022
  end-page: 572
  ident: CR52
  article-title: Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-022-01058-3
– volume: 68
  start-page: 26
  year: 2021
  end-page: 35
  ident: CR68
  article-title: Personalized dietary recommendations for weight loss: A scientific perspective from various angles
  publication-title: Ernahr. Umsch.
– volume: 106
  start-page: 902
  year: 2017
  end-page: 908
  ident: CR51
  article-title: Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: Results from the nutrient gene interactions in human obesity: Implications for dietary guidelines (NUGENOB) randomized trial
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.117.156281
– volume: 63
  start-page: E125
  year: 2022
  ident: CR47
  article-title: Polymorphisms, diet and nutrigenomics
  publication-title: J. Prev. Med. Hyg.
– volume: 2
  start-page: 193
  year: 2022
  end-page: 202
  ident: CR69
  article-title: Personalized nutrition for people with diabetes and at risk of diabetes has begun
  publication-title: J. Future Foods
  doi: 10.1016/j.jfutfo.2022.06.001
– volume: 45
  start-page: 322
  year: 2019
  end-page: 329
  ident: CR76
  article-title: Digital diabetes: Perspectives for diabetes prevention, management and research
  publication-title: Diabetes Metab.
  doi: 10.1016/j.diabet.2018.08.012
– volume: 55
  start-page: 314
  year: 2001
  end-page: 321
  ident: CR56
  article-title: Efficiency study of estimators for a treatment effect in a pretest–posttest trial
  publication-title: Am. Stat.
  doi: 10.1198/000313001753272466
– volume: 6
  start-page: 85
  year: 2004
  end-page: 94
  ident: CR65
  article-title: Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes—A systematic review
  publication-title: Diabetes Obes. Metab.
  doi: 10.1111/j.1462-8902.2004.00315.x
– volume: 36
  start-page: 927
  year: 2019
  end-page: 938
  ident: CR80
  article-title: Ethnicity and type 2 diabetes in the UK
  publication-title: Diabet. Med.
  doi: 10.1111/dme.13895
– volume: 20
  start-page: 2983
  year: 2019
  ident: CR53
  article-title: Nutritional factors, DNA methylation, and risk of type 2 diabetes and obesity: Perspectives and challenges
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20122983
– volume: 102
  start-page: 159
  year: 1987
  end-page: 163
  ident: CR57
  article-title: On the probability of making type I errors
  publication-title: Psychol. Bull.
  doi: 10.1037/0033-2909.102.1.159
– volume: 65
  start-page: 1839
  year: 2022
  end-page: 1848
  ident: CR72
  article-title: Precision nutrition in diabetes: When population-based dietary advice gets personal
  publication-title: Diabetologia
  doi: 10.1007/s00125-022-05721-6
– volume: 18
  start-page: 1
  year: 2021
  end-page: 12
  ident: CR50
  article-title: Personalised nutrition advice reduces intake of discretionary foods and beverages: Findings from the Food4Me randomised controlled trial
  publication-title: Int. J. Behav. Nutr. Phys. Act.
  doi: 10.1186/s12966-021-01136-5
– volume: 20
  start-page: 1
  year: 2022
  end-page: 13
  ident: CR43
  article-title: Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: A randomized dietary intervention pilot trial
  publication-title: BMC Med.
  doi: 10.1186/s12916-022-02254-y
– volume: 9
  start-page: 6
  year: 2012
  ident: CR1
  article-title: Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications
  publication-title: Rev. Diabet. Stud.
  doi: 10.1900/RDS.2012.9.6
– volume: 3
  start-page: 11
  year: 2018
  ident: CR37
  article-title: Polygenic risk score for predicting weight loss after bariatric surgery
  publication-title: JCI Insight
– volume: 348
  start-page: 1610
  year: 2014
  ident: CR29
  article-title: Fried food consumption, genetic risk, and body mass index: Gene–diet interaction analysis in three US cohort studies
  publication-title: BMJ
  doi: 10.1136/bmj.g1610
– volume: 6
  start-page: 378
  year: 2010
  end-page: 387
  ident: CR13
  article-title: A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes
  publication-title: Curr. Diabetes Rev.
  doi: 10.2174/157339910793499092
– volume: 8
  start-page: 535
  year: 2013
  end-page: 547
  ident: CR25
  article-title: Genetic susceptibility to obesity and diet intakes: Association and interaction analyses in the Malmö diet and cancer study
  publication-title: Genes Nutr.
  doi: 10.1007/s12263-013-0352-8
– volume: 340
  start-page: 698
  year: 2010
  end-page: 702
  ident: CR60
  article-title: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
  publication-title: BMJ
  doi: 10.1136/bmj.c332
– volume: 3
  start-page: 523
  year: 2021
  end-page: 529
  ident: CR45
  article-title: Postprandial glycaemic dips predict appetite and energy intake in healthy individuals
  publication-title: Nat. Metab.
  doi: 10.1038/s42255-021-00383-x
– volume: 375
  start-page: 2349
  year: 2016
  end-page: 2358
  ident: CR11
  article-title: Genetic risk, adherence to a healthy lifestyle, and coronary disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1605086
– volume: 3
  start-page: 693
  year: 2018
  end-page: 702
  ident: CR2
  article-title: Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study
  publication-title: JAMA Cardiol.
  doi: 10.1001/jamacardio.2018.1717
– volume: 16
  start-page: 545
  year: 2020
  end-page: 555
  ident: CR61
  article-title: Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/s41574-020-0381-5
– volume: 94
  start-page: e1126
  year: 2020
  end-page: e1136
  ident: CR23
  article-title: Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000008932
– volume: 10
  start-page: 1
  year: 2015
  end-page: 10
  ident: CR24
  article-title: A genetic risk tool for obesity predisposition assessment and personalized nutrition implementation based on macronutrient intake
  publication-title: Genes Nutr.
  doi: 10.1007/s12263-014-0445-z
– volume: 101
  start-page: 478
  year: 2009
  end-page: 481
  ident: CR41
  article-title: Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: Gene–diet interaction in modulating type 2 diabetes risk
  publication-title: Br. J. Nutr.
  doi: 10.1017/S0007114508020369
– volume: 3
  start-page: 49
  year: 2020
  end-page: 59
  ident: CR30
  article-title: Enhanced long-term dietary change and adherence in a nutrigenomics-guided lifestyle intervention compared to a population-based (GLB/DPP) lifestyle intervention for weight management: Results from the NOW randomised controlled trial
  publication-title: BMJ Nutr. Prev. Health
  doi: 10.1136/bmjnph-2020-000073
– volume: 6
  start-page: 29
  year: 2007
  ident: CR38
  article-title: Improved weight management using genetic information to personalize a calorie controlled diet
  publication-title: Nutr. J.
  doi: 10.1186/1475-2891-6-29
– volume: 34
  start-page: 1249
  year: 2011
  end-page: 1257
  ident: CR5
  article-title: Globalization of diabetes: The role of diet, lifestyle, and genes
  publication-title: Diabetes Care
  doi: 10.2337/dc11-0442
– ident: CR79
– volume: 90
  start-page: 1502
  year: 2009
  end-page: 1508
  ident: CR4
  article-title: Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.2009.28379
– volume: 61
  start-page: 3005
  year: 2012
  end-page: 3011
  ident: CR32
  article-title: FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: The POUNDS LOST trial
  publication-title: Diabetes
  doi: 10.2337/db11-1799
– volume: 6
  start-page: 1
  year: 2007
  end-page: 8
  ident: CR33
  article-title: Improved weight management using genetic information to personalize a calorie controlled diet
  publication-title: Nutr. J.
  doi: 10.1186/1475-2891-6-29
– volume: 13
  start-page: 4283
  year: 2021
  ident: CR10
  article-title: Unhealthy lifestyle, genetics and risk of cardiovascular disease and mortality in 76,958 individuals from the UK biobank cohort study
  publication-title: Nutrients
  doi: 10.3390/nu13124283
– volume: 17
  start-page: 495
  year: 2017
  end-page: 513
  ident: CR18
  article-title: Utilizing nutritional genomics to tailor diets for the prevention of cardiovascular disease: A guide for upcoming studies and implementations
  publication-title: Expert Rev. Mol. Diagn.
  doi: 10.1080/14737159.2017.1311208
– volume: 25
  start-page: 663
  year: 2023
  end-page: 677
  ident: CR22
  article-title: Precision nutrition and cardiovascular disease risk reduction: The promise of high-density lipoproteins
  publication-title: Curr. Atheroscler. Rep.
  doi: 10.1007/s11883-023-01148-5
– volume: 11
  start-page: 137
  year: 2012
  ident: CR42
  article-title: Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low
  publication-title: Cardiovasc. Diabetol.
  doi: 10.1186/1475-2840-11-137
– volume: 11
  start-page: 269
  year: 2000
  end-page: 273
  ident: CR64
  article-title: Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus?
  publication-title: Epidemiology
  doi: 10.1097/00001648-200005000-00007
– volume: 13
  start-page: 1
  year: 2016
  end-page: 9
  ident: CR48
  article-title: The effect of interaction between melanocortin-4 receptor polymorphism and dietary factors on the risk of metabolic syndrome
  publication-title: Nutr. Metab. (Lond.)
  doi: 10.1186/s12986-016-0092-z
– volume: 9
  start-page: 913
  year: 2017
  ident: CR17
  article-title: Precision nutrition: A review of personalized nutritional approaches for the prevention and management of metabolic syndrome
  publication-title: Nutrients
  doi: 10.3390/nu9080913
– volume: 12
  start-page: 393
  year: 2018
  end-page: 408
  ident: CR15
  article-title: Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis
  publication-title: Prim. Care Diabetes
  doi: 10.1016/j.pcd.2018.07.003
– volume: 86
  start-page: 752
  year: 2007
  end-page: 758
  ident: CR20
  article-title: GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/86.3.752
– volume: 367
  start-page: 1387
  year: 2012
  end-page: 1396
  ident: CR27
  article-title: Sugar-sweetened beverages and genetic risk of obesity
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1203039
– volume: 49
  start-page: 1441
  year: 2020
  end-page: 1442
  ident: CR66
  article-title: Cohort profile update: Southall and Brent revisited (SABRE) study: A UK population-based comparison of cardiovascular disease and diabetes in people of European, South Asian and African Caribbean heritage
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/dyaa135
– volume: 10
  start-page: 43
  year: 2017
  end-page: 62
  ident: CR70
  article-title: Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity
  publication-title: J. Nutrigenet. Nutrigenom.
– volume: 13
  start-page: 84
  year: 2020
  end-page: 98
  ident: CR36
  article-title: The combined effect of polygenic risk from FTO and ADRB2 gene variants, odds of obesity, and post-Hipcref diet differences
  publication-title: Lifestyle Genom.
  doi: 10.1159/000505662
– volume: 62
  start-page: 877
  year: 2019
  end-page: 887
  ident: CR73
  article-title: Digital health technology and mobile devices for the management of diabetes mellitus: State of the art
  publication-title: Diabetologia
  doi: 10.1007/s00125-019-4864-7
– volume: 346
  start-page: 393
  year: 2002
  end-page: 403
  ident: CR67
  article-title: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa012512
– start-page: 37
  year: 2010
  end-page: 96
  ident: CR58
  article-title: Random effects models for longitudinal data
  publication-title: Longitudinal Research with Latent Variables
  doi: 10.1007/978-3-642-11760-2_2
– volume: 2
  start-page: 637
  year: 2009
  end-page: 651
  ident: CR19
  article-title: Nutrigenomics in cardiovascular medicine
  publication-title: Circ. Cardiovasc. Genet.
  doi: 10.1161/CIRCGENETICS.109.891366
– volume: 44
  start-page: 2470
  year: 2021
  end-page: 2479
  ident: CR40
  article-title: Effect of diet quality and genetic predisposition on hemoglobin A1c and type 2 diabetes risk: Gene–diet interaction analysis of 357,419 individuals
  publication-title: Diabetes Care
  doi: 10.2337/dc21-1051
– volume: 104
  start-page: 816
  year: 2016
  end-page: 826
  ident: CR26
  article-title: Interactions between genetic variants associated with adiposity traits and soft drinks in relation to longitudinal changes in body weight and waist circumference
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.115.122820
– volume: 23
  start-page: 305
  year: 2015
  end-page: 312
  ident: CR34
  article-title: Genetic susceptibility testing and readiness to control weight: Results from a randomized controlled trial
  publication-title: Obesity
  doi: 10.1002/oby.20958
– volume: 26
  start-page: 211
  year: 1964
  end-page: 243
  ident: CR59
  article-title: An analysis of transformations
  publication-title: J. R. Stat. Soc. Ser. B (Methodol.)
– volume: 160
  start-page: 81
  year: 2019
  end-page: 100
  ident: CR7
  article-title: Impact of genes and environment on obesity and cardiovascular disease
  publication-title: Endocrinology
  doi: 10.1210/en.2018-00591
– volume: 33
  start-page: 1674
  year: 2010
  end-page: 1685
  ident: CR54
  article-title: Diabetes and cancer: A consensus report
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0666
– volume: 104
  start-page: 198
  year: 2016
  end-page: 204
  ident: CR39
  article-title: Genetic susceptibility to diabetes and long-term improvement of insulin resistance and β cell function during weight loss: The preventing overweight using novel dietary strategies (POUNDS LOST) trial
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.115.121186
– volume: 29
  start-page: 2102
  year: 2006
  end-page: 2107
  ident: CR62
  article-title: Effect of weight loss with lifestyle intervention on risk of diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc06-0560
– volume: 6
  start-page: 416
  year: 2018
  end-page: 426
  ident: CR71
  article-title: Precision nutrition for prevention and management of type 2 diabetes
  publication-title: Lancet Diabetes Endocrinol.
  doi: 10.1016/S2213-8587(18)30037-8
– volume: 11
  start-page: 1015
  year: 2017
  end-page: 1027
  ident: CR75
  article-title: A systematic review of reviews evaluating technology-enabled diabetes self-management education and support
  publication-title: J. Diabetes Sci. Technol.
  doi: 10.1177/1932296817713506
– volume: 68
  start-page: 682
  year: 2014
  ident: CR63
  article-title: The importance of weight management in type 2 diabetes mellitus
  publication-title: Int. J. Clin. Pract.
  doi: 10.1111/ijcp.12384
– volume: 6
  start-page: 378
  year: 2010
  ident: 55105_CR13
  publication-title: Curr. Diabetes Rev.
  doi: 10.2174/157339910793499092
– volume: 163
  start-page: 1079
  year: 2015
  ident: 55105_CR16
  publication-title: Cell
  doi: 10.1016/j.cell.2015.11.001
– volume: 6
  start-page: 7
  year: 2020
  ident: 55105_CR35
  publication-title: BMC Nutr.
  doi: 10.1186/s40795-020-00370-7
– volume: 6
  start-page: 1
  year: 2007
  ident: 55105_CR33
  publication-title: Nutr. J.
  doi: 10.1186/1475-2891-6-29
– volume: 160
  start-page: 81
  year: 2019
  ident: 55105_CR7
  publication-title: Endocrinology
  doi: 10.1210/en.2018-00591
– volume: 6
  start-page: 85
  year: 2004
  ident: 55105_CR65
  publication-title: Diabetes Obes. Metab.
  doi: 10.1111/j.1462-8902.2004.00315.x
– volume: 26
  start-page: 964
  year: 2020
  ident: 55105_CR44
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0934-0
– volume: 16
  start-page: 545
  year: 2020
  ident: 55105_CR61
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/s41574-020-0381-5
– volume: 11
  start-page: 269
  year: 2000
  ident: 55105_CR64
  publication-title: Epidemiology
  doi: 10.1097/00001648-200005000-00007
– volume: 54
  start-page: 560
  year: 2022
  ident: 55105_CR52
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-022-01058-3
– volume: 3
  start-page: 523
  year: 2021
  ident: 55105_CR45
  publication-title: Nat. Metab.
  doi: 10.1038/s42255-021-00383-x
– volume: 10
  start-page: 1
  year: 2015
  ident: 55105_CR24
  publication-title: Genes Nutr.
  doi: 10.1007/s12263-014-0445-z
– volume: 13
  start-page: 84
  year: 2020
  ident: 55105_CR36
  publication-title: Lifestyle Genom.
  doi: 10.1159/000505662
– volume: 29
  start-page: 2102
  year: 2006
  ident: 55105_CR62
  publication-title: Diabetes Care
  doi: 10.2337/dc06-0560
– volume: 104
  start-page: 198
  year: 2016
  ident: 55105_CR39
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.115.121186
– volume: 33
  start-page: 1674
  year: 2010
  ident: 55105_CR54
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0666
– volume: 49
  start-page: 223
  year: 2015
  ident: 55105_CR55
  publication-title: Am. J. Prev. Med.
  doi: 10.1016/j.amepre.2015.01.003
– volume: 65
  start-page: 1839
  year: 2022
  ident: 55105_CR72
  publication-title: Diabetologia
  doi: 10.1007/s00125-022-05721-6
– volume: 83
  start-page: 443S
  year: 2006
  ident: 55105_CR21
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/83.2.443S
– volume: 26
  start-page: 211
  year: 1964
  ident: 55105_CR59
  publication-title: J. R. Stat. Soc. Ser. B (Methodol.)
  doi: 10.1111/j.2517-6161.1964.tb00553.x
– volume: 68
  start-page: 26
  year: 2021
  ident: 55105_CR68
  publication-title: Ernahr. Umsch.
– volume: 94
  start-page: e1126
  year: 2020
  ident: 55105_CR23
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000008932
– volume: 348
  start-page: 1610
  year: 2014
  ident: 55105_CR29
  publication-title: BMJ
  doi: 10.1136/bmj.g1610
– ident: 55105_CR79
  doi: 10.2337/cd20-pe04
– volume: 45
  start-page: 322
  year: 2019
  ident: 55105_CR76
  publication-title: Diabetes Metab.
  doi: 10.1016/j.diabet.2018.08.012
– volume-title: Social Environmental and Genetic Influences on Obesity and Obesity-Promoting Behaviors: Fostering Research Integration
  year: 2006
  ident: 55105_CR8
– volume: 2
  start-page: 637
  year: 2009
  ident: 55105_CR19
  publication-title: Circ. Cardiovasc. Genet.
  doi: 10.1161/CIRCGENETICS.109.891366
– volume: 102
  start-page: 159
  year: 1987
  ident: 55105_CR57
  publication-title: Psychol. Bull.
  doi: 10.1037/0033-2909.102.1.159
– volume: 104
  start-page: 816
  year: 2016
  ident: 55105_CR26
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.115.122820
– volume: 2
  start-page: 193
  year: 2022
  ident: 55105_CR69
  publication-title: J. Future Foods
  doi: 10.1016/j.jfutfo.2022.06.001
– volume: 86
  start-page: 752
  year: 2007
  ident: 55105_CR20
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/86.3.752
– volume: 61
  start-page: 3005
  year: 2012
  ident: 55105_CR32
  publication-title: Diabetes
  doi: 10.2337/db11-1799
– volume: 10
  start-page: 43
  year: 2017
  ident: 55105_CR70
  publication-title: J. Nutrigenet. Nutrigenom.
– volume: 44
  start-page: 2470
  year: 2021
  ident: 55105_CR40
  publication-title: Diabetes Care
  doi: 10.2337/dc21-1051
– volume: 3
  start-page: 11
  year: 2018
  ident: 55105_CR37
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.122011
– volume: 90
  start-page: 1502
  year: 2009
  ident: 55105_CR4
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.2009.28379
– volume: 159
  start-page: 543
  year: 2013
  ident: 55105_CR14
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-159-8-201310150-00007
– volume: 367
  start-page: 1387
  year: 2012
  ident: 55105_CR27
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1203039
– volume: 34
  start-page: 1249
  year: 2011
  ident: 55105_CR5
  publication-title: Diabetes Care
  doi: 10.2337/dc11-0442
– volume: 106
  start-page: 902
  year: 2017
  ident: 55105_CR51
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.117.156281
– volume: 68
  start-page: 682
  year: 2014
  ident: 55105_CR63
  publication-title: Int. J. Clin. Pract.
  doi: 10.1111/ijcp.12384
– volume: 62
  start-page: 877
  year: 2019
  ident: 55105_CR73
  publication-title: Diabetologia
  doi: 10.1007/s00125-019-4864-7
– volume: 23
  start-page: 305
  year: 2015
  ident: 55105_CR34
  publication-title: Obesity
  doi: 10.1002/oby.20958
– volume: 9
  start-page: 913
  year: 2017
  ident: 55105_CR17
  publication-title: Nutrients
  doi: 10.3390/nu9080913
– volume: 55
  start-page: 314
  year: 2001
  ident: 55105_CR56
  publication-title: Am. Stat.
  doi: 10.1198/000313001753272466
– volume: 12
  start-page: 4
  year: 2018
  ident: 55105_CR3
  publication-title: Am. J. Lifestyle Med.
  doi: 10.1177/1559827615619159
– volume: 12
  start-page: 3768
  year: 2020
  ident: 55105_CR31
  publication-title: Nutrients
  doi: 10.3390/nu12123768
– volume: 11
  start-page: 1015
  year: 2017
  ident: 55105_CR75
  publication-title: J. Diabetes Sci. Technol.
  doi: 10.1177/1932296817713506
– start-page: 37
  volume-title: Longitudinal Research with Latent Variables
  year: 2010
  ident: 55105_CR58
  doi: 10.1007/978-3-642-11760-2_2
– volume: 13
  start-page: 4283
  year: 2021
  ident: 55105_CR10
  publication-title: Nutrients
  doi: 10.3390/nu13124283
– volume: 3
  start-page: 693
  year: 2018
  ident: 55105_CR2
  publication-title: JAMA Cardiol.
  doi: 10.1001/jamacardio.2018.1717
– volume: 11
  start-page: 137
  year: 2012
  ident: 55105_CR42
  publication-title: Cardiovasc. Diabetol.
  doi: 10.1186/1475-2840-11-137
– volume: 36
  start-page: 383
  year: 2013
  ident: 55105_CR77
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0544
– volume: 12
  start-page: 393
  year: 2018
  ident: 55105_CR15
  publication-title: Prim. Care Diabetes
  doi: 10.1016/j.pcd.2018.07.003
– volume: 18
  start-page: 1
  year: 2021
  ident: 55105_CR50
  publication-title: Int. J. Behav. Nutr. Phys. Act.
  doi: 10.1186/s12966-021-01136-5
– volume: 346
  start-page: 393
  year: 2002
  ident: 55105_CR67
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa012512
– volume: 3
  start-page: 49
  year: 2020
  ident: 55105_CR30
  publication-title: BMJ Nutr. Prev. Health
  doi: 10.1136/bmjnph-2020-000073
– volume: 63
  start-page: E125
  year: 2022
  ident: 55105_CR47
  publication-title: J. Prev. Med. Hyg.
– volume: 20
  start-page: 2983
  year: 2019
  ident: 55105_CR53
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20122983
– volume: 20
  start-page: 1
  year: 2022
  ident: 55105_CR43
  publication-title: BMC Med.
  doi: 10.1186/s12916-022-02254-y
– volume: 25
  start-page: 663
  year: 2023
  ident: 55105_CR22
  publication-title: Curr. Atheroscler. Rep.
  doi: 10.1007/s11883-023-01148-5
– volume: 105
  start-page: 1204
  year: 2017
  ident: 55105_CR49
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.116.145680
– volume: 24
  start-page: 4728
  year: 2015
  ident: 55105_CR6
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddv186
– volume: 386
  start-page: 951
  year: 2022
  ident: 55105_CR9
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2116747
– volume: 6
  start-page: 29
  year: 2007
  ident: 55105_CR38
  publication-title: Nutr. J.
  doi: 10.1186/1475-2891-6-29
– volume: 5
  start-page: 1
  year: 2019
  ident: 55105_CR12
  publication-title: Clin. Diabetes Endocrinol.
  doi: 10.1186/s40842-019-0080-0
– volume: 9
  start-page: 6
  year: 2012
  ident: 55105_CR1
  publication-title: Rev. Diabet. Stud.
  doi: 10.1900/RDS.2012.9.6
– volume: 36
  start-page: 927
  year: 2019
  ident: 55105_CR80
  publication-title: Diabet. Med.
  doi: 10.1111/dme.13895
– volume: 6
  start-page: 416
  year: 2018
  ident: 55105_CR71
  publication-title: Lancet Diabetes Endocrinol.
  doi: 10.1016/S2213-8587(18)30037-8
– volume: 375
  start-page: 2349
  year: 2016
  ident: 55105_CR11
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1605086
– volume: 37
  start-page: 100960
  year: 2021
  ident: 55105_CR78
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2021.100960
– volume: 49
  start-page: 1441
  year: 2020
  ident: 55105_CR66
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/dyaa135
– volume: 17
  start-page: 495
  year: 2017
  ident: 55105_CR18
  publication-title: Expert Rev. Mol. Diagn.
  doi: 10.1080/14737159.2017.1311208
– volume: 101
  start-page: 478
  year: 2009
  ident: 55105_CR41
  publication-title: Br. J. Nutr.
  doi: 10.1017/S0007114508020369
– volume: 114
  start-page: 1954
  year: 2014
  ident: 55105_CR28
  publication-title: J. Acad. Nutr. Diet
  doi: 10.1016/j.jand.2014.03.014
– volume: 54
  start-page: 14
  year: 2023
  ident: 55105_CR46
  publication-title: Atheroscler. Plus
  doi: 10.1016/j.athplu.2023.09.002
– volume: 13
  start-page: 1
  year: 2016
  ident: 55105_CR48
  publication-title: Nutr. Metab. (Lond.)
  doi: 10.1186/s12986-016-0092-z
– volume: 210
  start-page: 106370
  year: 2021
  ident: 55105_CR74
  publication-title: Comput. Methods Progr. Biomed.
  doi: 10.1016/j.cmpb.2021.106370
– volume: 8
  start-page: 535
  year: 2013
  ident: 55105_CR25
  publication-title: Genes Nutr.
  doi: 10.1007/s12263-013-0352-8
– volume: 340
  start-page: 698
  year: 2010
  ident: 55105_CR60
  publication-title: BMJ
  doi: 10.1136/bmj.c332
SSID ssj0000529419
Score 2.4629579
Snippet Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine...
Abstract Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to...
SourceID doaj
pubmedcentral
hal
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5428
SubjectTerms 692/700/2814
692/700/459
692/700/478
Deoxyribonucleic acid
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - prevention & control
DNA
Female
Glucose
Glycated Hemoglobin
Humanities and Social Sciences
Humans
Hyperglycemia
Intervention
Life Sciences
Male
Middle Aged
multidisciplinary
NCT
NCT03702465
Pilot Projects
Science
Science (multidisciplinary)
SummonAdditionalLinks – databaseName: Science Database
  dbid: M2P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWggMSF70KgIIO4QdTEsRObC1oQVQ-l6gFQb5ZjO-2KkiybbRE_gv_MjOOkLBW9cNskthPvjD3PnvEbQl5yV0pRO5aW1piUCwVjzps6tUi8AsuB3AUqpS971f6-PDxUB3HDrY9hleOcGCZq11ncI98Gs1RxVcKC5e3ie4pZo9C7GlNoXCXXANnkGNL1kR1MeyzoxeK5imdlskJu92Cv8EwZ46lAaJGWa_Yo0PaDlTnGoMiLiPNi4ORf3tNglHZu_2937pBbEY7S2aA_d8kV394jN4YElT_vk1-zibiTdg0FsEiHY5V4ZehiRPK9d7Qdef3p_I84SrgIVWBmdTTGx9OlP4pZwyhGkFJW0h_ef-3fQJtgO133LbQYw-hP4GdILvKAfN758On9bhoTOKQWUOAqZXnTKClkUxiwiXXOK--VY07xynJY0jeqFtzkRePzomwAKlrhCtCpUjGbudoUm2Sj7Vr_iFBnAKtAVcOM5A6mRpc5CWhMWeMrz-qE5KMYtY3s5phk40QHL3sh9SB6DaLXQfS6TMirqc5i4Pa4tPQ71I6pJPJyhxvd8kjHYa59JlyTOdd4Lzj0StWl5MJkCmGZdS4hL0C31trYne1pvAfYWhRKyrM8IVujzug4o_T6XGES8nx6DOJAB49pfXcayiAhoZQyIQ8HTZ1eVUjOC86qhMg1HV77lvUn7fw48I0jdyyvBFR9Par7-Xf9-w97fHk3npCbDMchxvOJLbKxWp76p-S6PVvN--WzMJB_A-tQUgA
  priority: 102
  providerName: ProQuest
Title Assessment of the impact of a personalised nutrition intervention in impaired glucose regulation over 26 weeks: a randomised controlled trial
URI https://link.springer.com/article/10.1038/s41598-024-55105-6
https://www.ncbi.nlm.nih.gov/pubmed/38443427
https://www.proquest.com/docview/2937496721
https://www.proquest.com/docview/2938285888
https://hal.science/hal-04553988
https://pubmed.ncbi.nlm.nih.gov/PMC10914757
https://doaj.org/article/e05df0ddfee54e139b6845a090910cdd
Volume 14
WOSCitedRecordID wos001180457200034&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M7P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M2P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB5BCxIXxD-BsjKIG0RNHDu2uW1RqyK1qwgBWk6WEzvqipKtNtsiXoJn4Fl4MsZONuxSARcuVhL_xPKMPZ_l8TcAz5nNJS8tjfPKmJhxhXPOmTKuPPEKbgdSG6iUPhyJyUROp6pYC_XlfcI6euBu4HZdwm2dWFs7x5lDvFLmknGTKG_oKmv96psItbaZ6li9qWKp6m_JJJncbdFS-dtklMXcg4o437BEgbAf7cuJd4e8jDUvu0z-dm4azNHBLbjZ40gy7vp_G6645g5c7yJLfr0L38YD4yaZ1wRRHunuQ_o3Q85WELx1ljQrQn4yW3OAxJdQBZdES3rHdrLoItf7bO_6SWj-4_sX5z61r7BRtHp2_jk02TvAn-JjCAtyD94f7L97fRj3oRfiCvHbMqZpXSvJZZ0ZtGZlyoRzylKrmKgYbsZrVXJm0qxGieQ1gryK2wy1IVe0Smxpsvuw1cwb9xCINYgysKqhRjKLi5pNrEQcpSrjhKNlBOlKDLrqecl9eIxTHc7HM6k70WkUnQ6i03kEL4Y6Zx0rx19L73npDiU9o3b4gHqmez3T_9KzCJ6hbmy0cTg-0v4bomKeKSkv0gh2Vqqj-7Wg1QioBFM5brUjeDpkozj80Yxp3Pw8lPFUglLKCB50mjb8KpOMZYyKCOSGDm70ZTOnmZ0EpnDP-soEx6ovV-r6q19_HrBH_2PAHsMN6meb99fjO7C1XJy7J3CtuljO2sUIroqpCKkcwfbe_qR4OwpTGNNjWvhUYLpdvDkuPv4E9XVM8g
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKAcGFfQkUMAhOEDVx7MRGQmhYqqk6VD0U1JtxYqcdUZJhZtqqP4K_wm_kPWcpQ0VvPXDLYjux89b4ve8R8pzbVIrcsjAtjAm5UMBzzuRhgcAr4A7E1kMpfRllm5tyZ0dtLZFfXS4MhlV2MtELalsX-I98FdRSxlUKDsvbyY8Qq0bh7mpXQqMhiw13fAQu2-zN-gf4vi8YW_u4_X4YtlUFwgJMk3nI4rJUUsgyMSCo85hnzinLrOJZwcHPLFUuuImT0sVJWoL9UgibwERTxYrI5iaBcS-QixyRxTBUkG31_3Rw14zHqs3NiRK5OgP9iDlsjIcCTZkwXdB_vkwAaLU9DMI8beGeDtT8a7fWK8G16__b8t0g11pzmw4a_rhJllx1i1xuCnAe3yY_Bz0wKa1LCsYwbdJG8czQSeepzJylVVe3gI7_iBOFE98FNIelbfw_nbrdtioaxQhZylJ65Ny32WsYE2wDW3_3I7ZpAvtw6Iun3CGfz2Ut7pLlqq7cfUKtAVsMuhpmJLcg-m1kJVibqjAucywPSNyRjS5a9HYsIrKvfRRBInVDahpITXtS02lAXvZ9Jg12yZmt3yE19i0Rd9xfqKe7uhVj2kXClpG1pXOCw6xUnkouTKTQ7CysDcgzoOWFMYaDkcZr4DuIREl5GAdkpaNR3UrMmT4h0IA87W_D58ANLFO5-sC3QcBFKWVA7jWc0T8qkZwnnGUBkQs8s_Aui3eq8Z7HU0dsXJ4J6PqqY6-T9_r3gj04expPyJXh9qeRHq1vbjwkVxnKAIxdFCtkeT49cI_IpeJwPp5NH3shQsnX82a731nYsI8
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLbKFBAX9iVQwCA4QTSJYyc2EkIDZdRRh9EcAJWTcWKnHVGSYTJt1R_BH-LX8ewsZajorQduWWwndt7yvfgtCD2jOuYs1cSPM6V8ygTwnFGpn9nEK2AOhNqlUvo8TiYTvrMjpmvoVxsLY90qW5noBLUuM_uPvA9qKaEiBoOlnzduEdPN4Zv5D99WkLI7rW05jZpEts3xEZhv1evRJnzr54QM3398t-U3FQb8DGDK0idhngvOeB4pENppSBNjhCZa0CSjYHPmImVUhVFuwijOActkTEcw6ViQLNCpimDcC2gdIDklPbQ-HX2Yfun-8Ng9NBqKJlIniHi_Am1pI9oI9ZkFNn68og1d0QDQcXvWJfM03j3ttvnX3q1TicNr__NiXkdXGyCOBzXn3EBrpriJLtWlOY9voZ-DLmUpLnMMMBnXAaX2TOF5a8NURuOirWiAZ394kMKJ6wI6ReMmMgAvzG5TLw1b31lMYnxkzLfqFYwJqEGX392ITQDBPhy6siq30adzWYs7qFeUhbmHsFaA0qCrIopTDUpBB5oDDhWZMokhqYfCloRk1uR1t-VF9qXzL4i4rMlOAtlJR3Yy9tCLrs-8zmpyZuu3ljK7ljYjubtQLnZlI-CkCZjOA61zYxiFWYk05pSpQFhAmmntoadA1ytjbA3G0l4Dq4JFgvPD0EMbLb3KRpZW8oRYPfSkuw2fw25tqcKUB66NTcXIOffQ3ZpLukdFnNKIksRDfIV_Vt5l9U4x23OZ1m3WXJow6PqyZbWT9_r3gt0_exqP0WXgNjkeTbYfoCvEigPr1Mg2UG-5ODAP0cXscDmrFo8aiYLR1_Pmu993nLrY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+the+impact+of+a+personalised+nutrition+intervention+in+impaired+glucose+regulation+over+26%C2%A0weeks%3A+a+randomised+controlled+trial&rft.jtitle=Scientific+reports&rft.au=Maria+Karvela&rft.au=Caroline+T.+Golden&rft.au=Nikeysha+Bell&rft.au=Stephanie+Martin-Li&rft.date=2024-03-05&rft.pub=Nature+Portfolio&rft.eissn=2045-2322&rft.volume=14&rft.issue=1&rft.spage=1&rft.epage=13&rft_id=info:doi/10.1038%2Fs41598-024-55105-6&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e05df0ddfee54e139b6845a090910cdd
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon